CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive dose, spike gene mRNA/spike gene…
Category: Editorial
Adapted from: India Legal, https://www.indialegallive.com/column-news/covid-rise-cases/Published April 10, 2021 Cases of coronaviruses are rising swiftly in the ongoing second wave of Covid-19 with over one lakh new cases now being recorded in the country…
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive dose, spike gene mRNA/spike gene…
With input from Dr Monica Vasudev 1562: Moderna says its coronavirus vaccine provides strong protection up to 6 months after a second dose. The company stated that updated cases point to…
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive dose, spike gene mRNA/spike gene…